Solstice Advanced Materials Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Solstice Advanced Materials Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
Revenue
3,649
3,770
3,886
Cost of revenue
2,366
2,464
2,636
Gross profit
1,283
1,306
1,250
Research and development
81
83
97
Selling, general and administrative
378
392
421
Interest expense
16
13
28
Other non-operating income
7
5
60
Pre-tax income
814
797
647
Income tax
195
192
362
Net income to minority interests
-2
11
48
Net income
621
594
237
EPS, basic
3.91
3.74
1.49
EPS, diluted
3.91
3.74
1.49
Shares, basic (weighted)
159
159
159
Shares, diluted (weighted)
159
159
159
Balance sheet
FY2023
FY2025
FY2025
Cash and equivalents
606
661
534
Receivables
569
645
Inventory
558
715
Other current assets
73
193
Total current assets
1,861
2,388
Property, plant and equipment
1,746
2,055
Lease right-of-use assets
90
89
Goodwill
814
806
820
Intangible assets
35
49
Other non-current assets
142
192
Total assets
5,004
5,673
Accounts payable
778
909
Accrued liabilities
283
68
Deferred revenue
6
3
Short-term debt
0
4
Total current liabilities
1,083
1,713
Long-term debt
0
1,968
Lease liabilities
64
69
Other non-current liabilities
230
262
Total liabilities
1,822
4,296
Total debt
0
2,000
Paid-in capital
0
1,495
Retained earnings
0
41
Other comprehensive income
-213
-127
Shareholders' equity
3,258
1,411
Minority interests
-76
-34
Total equity
3,028
3,182
1,377
Total liabilities and equity
5,004
5,673
Shares outstanding
0
159
Cash flow statement
FY2023
FY2025
FY2025
Net income
619
605
285
Depreciation and amortization
48
39
24
Stock-based compensation
18
17
27
Deferred income tax
-36
-6
-26
Change in receivables
-134
40
-51
Change in inventory
-78
-16
-146
Change in payables
78
12
77
Cash from operations
760
842
455
Capital expenditures
-299
-296
-336
Cash from investing
-324
-298
-330
Debt issued
0
0
2,000
Dividends paid
0
0
-1,500
Cash from financing
-378
-453
-235
Net change in cash
57
55
-126
Free cash flow
461
546
119
Income taxes paid
24
22
50
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $56.65 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
30.6%
Gross profit / revenue.
Pre-tax margin
13.9%
Pre-tax income / revenue.
Net margin
5.1%
Net income / revenue.
FCF margin
4.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
14.8%
Cash from operations / revenue.
Effective tax rate
50.3%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
13.2%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
3.5%
Net income / average total assets.
R&D / revenue
2.6%
Research and development expense / revenue.
SG&A / revenue
11.1%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
10.0%
Capital expenditures / revenue.
D&A / revenue
4.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
3.1%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-4.3%
Gross profit vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
-60.1%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-60.2%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-46.0%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-78.2%
Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-56.7%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
13.4%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
0.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.46x
Current assets / current liabilities.
Quick ratio
0.81x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.43x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.24x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
33.3%
Total debt / total assets.
Liabilities / assets
73.2%
Total liabilities / total assets.
Net debt
$1.22B
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
FCF conversion
92.9%
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
67.8%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$1.32
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$25.69
Revenue / diluted weighted shares.
FCF per share
$1.22
Free cash flow / diluted weighted shares.
Operating cash flow per share
$3.80
Cash from operations / diluted weighted shares.
Book value per share
$9.98
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
42.9x
Market cap / net income. Only when net income is positive.
P/S
2.20x
Market cap / revenue.
P/B
5.67x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
12.5x
Market cap / tangible book value, when positive.
P/FCF
46.1x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
14.8x
Market cap / cash from operations, when positive.
EV/Sales
2.50x
Enterprise value / revenue.
EV/FCF
52.4x
Enterprise value / free cash flow, when both are positive.
FCF yield
2.2%
Free cash flow / market cap.
Earnings yield
2.3%
Net income / market cap (the inverse of P/E).
What was Solstice Advanced Materials Inc.'s revenue in fiscal 2025?
Solstice Advanced Materials Inc. reported revenue of $3.89B for fiscal 2025, 3.1% higher than the year before.
Was Solstice Advanced Materials Inc. profitable in fiscal 2025?
Yes. Net income was $237.0M, a net margin of 6.1%.
How much free cash flow did Solstice Advanced Materials Inc. generate in fiscal 2025?
Cash from operations of $455.0M minus capital expenditures of $336.0M left free cash flow of $119.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.